(NP (NP A/DT novel/JJ HIV-1/NN isolate/JJ) (VP containing/VBG (NP (NP alterations/NNS) (VP affecting/VBG (NP the/DT NF-kappa/NN B/NN element/NN)))) ./.)
(S (NP-SBJ (NP (NP Three/CD molecular/JJ clones/NNS) (PP of/IN (NP HIV-1/NN))) ,/, (VP derived/VBN (NP */-NONE-) (PP from/IN (NP (NP a/DT single/JJ isolate/NN) (PRN -LRB-/-LRB- (NP AL1/NN) -RRB-/-RRB-)))) ,/,) (VP exhibited/VBD (NP distinct/JJ (ADJP-COOD (ADJP replicative/JJ) and/CC (ADJP cytopathic/JJ)) properties/NNS) (PP-TMP during/IN (NP (NP propagation/NN) (PP in/IN (NP a/DT human/JJ T/NN cell/NN line/NN))))) ./.)
(S (NP-SBJ (NP The/DT phenotypic/JJ differences/NNS) (VP observed/VBN (NP */-NONE-))) (VP were/VBD (ADJP-PRD attributable/JJ (PP *ICH*-105/-NONE-)) ,/, (PP in/IN (NP large/JJ part/NN)) ,/, (PP-105 to/TO (NP (NP changes/NNS) (VP affecting/VBG (NP the/DT viral/JJ LTR/NN))))) ./.)
(S (NP-SBJ-COOD (NP Nucleotide/NN sequence/NN) and/CC (NP PCR/NN analyses/NNS)) (VP demonstrated/VBD (NP (NP the/DT presence/NN) (PP of/IN (NP novel/JJ (NP (NP-COOD (NP duplications/NNS) or/CC (NP deletions/NNS)) (VP involving/VBG (NP the/DT NF-kappa/NN B/NN motif/NN))))))) ./.)
(S (NP-SBJ-54 (NP These/DT changes/NNS) (PP in/IN (NP the/DT enhancer/NN element/NN))) (VP were/VBD (VP identified/VBN (NP *-54/-NONE-) (PP in/IN (NP the/DT original/JJ AL1/NN virus/NN stock/NN)))) ./.)
(S (NP-SBJ (NP Subcloning/NN) (PP of/IN (NP the/DT variant/JJ NF-kappa/NN B/NN segments/NNS)) (PP into/IN (NP LTR-driven/JJ CAT/NN expression/NN vectors/NNS))) (VP confirmed/VBD (NP (NP a/DT correlation/NN) (PP between/IN (NP-COOD (NP promoter/JJ activity/NN) and/CC (NP (ADJP replicative\/cytopathic/JJ) capacity/NN))))) ./.)
